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A facile synthesis of 7-aryl-3-ethylimidazo[1,2-d]-
s-triazolo[3,4-b][1,3,4]thiadiazole 3 has been achieved
by the condensation of 4-amino-3-ethyl-5-mercapto-s-
. triazole 1 with cyanogen bromide to yield 6-amino-3-
ethyl-s-triazolo[3,4-b][ 1,3,4]thiadiazole 2 followed by
treatment with u-haloketones. The structures 3 are sup-
ported by IR and IH NMR spectral data. The anti-
bacterial and antifungal activities of the system have
also been evaluated.
Imidazole compounds exhibit antibacterial I, anti in-
flarnrnatory', hypertensive and anticonvulsive3 ac-
tivities whereas s-triazole system displays diuretic
and natriuretic activities". Our earlier work on the
synthesis of novel bridgehead nitrogen heterocyclic
systems" and the applications of imidazoles as
anthelminticsll and nematocides" stimulated con-
siderable interest in exploring the possible synthe-
sis of a potential condensed heterocyclic system in
which a biologically active thiadiazole nucleus is
fused to two other biologically active imidazole
and s-triazole nuclei, resulting in the synthesis of
imidazo[1 ,2-d]-s-triazolo[3,4-b][ 1,3,4]thiadiazole 3,
another novel and hitherto unknown heterocyclic
system. We report in this communication the syn-
Note
thesis of this novel system derived from 4-amino-
3-ethyl-5-mercapto-s-triazole and the associated
biological activities.
4-Amino-3-ethyl-5-mercapto-s-triazole 113 on
condensation with cyanogen bromide afforded 6-
amino-3-ethyl-s-triazolo[3,4-b][ 1,3,4]thiadiazole 2.
The structural assignment of 2 was supported by IR
and IH NMR spectral data (vide Experimental).
Condensation of 2 with u-haloketones furnished 7-
aryl-3-ethylimidazo[ 1,2-d]-s-triazolo[3,4-b] [1,3,4]-
thiadiazole 3. Lack of an absorption band in the IR
spectra of 3 in the region 1670-1700 em -I showed
the absence of a carbonyl group, thereby suggest-
ing a cyclic structure for 3. The appearance of a
signal at 0 6.36 (IH, s, C6-H) in the IH NMR
spectrum of 3a (R=CI) corroborated the cyclic
structure.
The structures 3 were established by elemental
analysis, IR and IH NMR spectral data (vide Ex-
.perimental),
Antimicrobial Activity. The compounds 3a
(R=Cl) and 3b (R=Br) were evaluated for their an-
timicrobial activity against the gram-positive
Staphylococcus aureus, the gram-negative Escher-
ichia coli and Pseudomonas aeruginosa and the
fungus Candida albicans by neat samples and se-
rial plate dilution method 14.
The minimum inhibitory concentrations (MIC)
of 3a and 3b against C. albicans were found to be
500 ug/ml., Compounds 3a and 3b were found to
be active against E. coli, S. aureus and P. aerugi-
nosa, when tested as neat samples, and may be
used for local application in the form of powder or
i CNBr, ii ArCOCH2Br
Scheme I
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ointment provided further studies indicate the ab-
sence oftoxicity following local application.
Experimental Section
TLC was run on silica gel G plates using ace-
tone-benzene (l :3) as solvent system. Melting
points are uncorrected. IR (KBr)(vrnax in em") and
IH NMR (CDCh) (0, ppm) spectra were recorded
on Hitachi 215 and Varian VXR-200 MHz spec-
trometers, respectively.
4-Amino-3-ethyl-5-mercapto-s-triazole 1. A
mixture of thiocarbohydrazide (lOg) and n-pro-
pionic acid (30 mL) was refluxed for 4 hr. The re-
action mixture was cooled to room temperature and
excess propionic acid distilled off under reduced
pressure. The residual solid was crystallised from
methanol as colourless crystals, m.p. 15PC (lit. 13,
m.p.=154°C).
6-Amino-3-ethyl-s-triazolo-[3,4-b] [1,3,4[thiadia-
zole 2. A mixture of 1 (1.44 g, 0.01 mole) and cya-
nogen bromide (1.05 g, 0.01 mole) in ethanol (60
mL) was heated under reflux, on a water-bath for 6
hr, cooled to room temperature and neutralised
with potassium carbonate solution to give a white
solid, which was recrystallised from methanol as
colourless shining crystals, m.p. 260°C, yield 0.85
g (50%). Anal. Calcd for CSH7NSS: N, 41.42; S,
18.93. Found: N, 41.77; S, 19.28%; IR: 1520
(C-N), 1630 (N-H in-plane-bending) 3220, 3270
(N-H); IH NMR (DMSO-d6): 1.27 (t, 3H, J=7.6
Hz, CH3), 2.83 (q, 2H, .1=7.6 Hz, CH2), 7.75 (s, 2H,
NH2). ~
7-(p-Chlorophenyl)-3-ethylimidazo [l;l-a]-s-tria-
zolo[3,4-b][l,3,4]thiadiazole 3a (R=CI). A mixture
of 2 (1.69 g, 0.01 mole) and p-chlorophenacyl bro-
mide (2.34 g, 0.01 mole) in anhydrous ethanol (100
mL) was heated under reflux for 6 hr and cooled to
room temperature. The solid that separated was fil-
tered, washed with water and crystallised from etha-
nol, as white shining needles, m.p. >250°C, yield 1.2'
g (31.25%). Anal. Calcd for C\3HllNsSBrCl: C,
40.63; H, 2.86; N, 18.23; S, 8.33. Found: C, 40.37; H,
2.63; N, 18.51; S, 8.17%; IR: 800 (l,4-disubstituted
benzene ring) 1525 (C-N), 1580, 1600 (C=C and
C=N) 3010 (aromatic C-H); IHNMR (DMSO-d6):
1.34 (1, 3H, .1=7.6 Hz, CH3), 3.02 (q, 2H, .1=7.6 Hz,
CH2), 6.36 (s, IH, C6-H), 7.85 [d, 2H, .1=8.6 Hz, H-3'
and H-5'), 8.00 [d, 2H,.1=8.6 Hz, H-2' and H-6'), 8.65
+ .
(s, IH, NH, exchangeable with D20).
3b (R=Br). A similar procedure was adopted for'
the synthesis of 3b (R=Br), m.p. >250°C, yield
48%. Anal. Calcd for C\3HllNsSBr2: C, 36.36; H,
2.56; N, 16.31 and S, 7.46. Found: C, 36.52; H,
2.70; N,16.18; S, 7.78%.
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